3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Vomiting
2
Ventilator-Induced Lung Injury
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Substance-Related Disorders
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pituitary Neoplasms
1
Pancreatic Neoplasms
1
Opioid-Related Disorders
1
Opioid-Induced Constipation
1
Neoplasms
1
Motor Activity
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Low Anterior Resection Syndrome
1
Kidney Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
Breast Neoplasms
1
Agnosia
1
Acromegaly
1
Interventions
Morphine
10
Methadone
6
Acetaminophen
5
Oxycodone
4
Lidocaine
4
Fentanyl
4
Ethanol
4
Acupuncture Therapy
4
Transcutaneous Electric Nerve Stimulation
3
Buprenorphine
3
Transcranial Direct Current Stimulation
2
Surveys and Questionnaires
2
Sodium Bicarbonate
2
Radiosurgery
2
Radiofrequency Ablation
2
Pharmaceutical Services
2
Ketamine
2
Electroacupuncture
2
Control Groups
2
Analgesics, Opioid
2
oxycodone naloxone combination
1
nabiximols
1
incobotulinumtoxinA
1
Water
1
Tramadol
1
Therapeutic Touch
1
Telemedicine
1
Tapentadol
1
Tablets
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cancer Pain
×
Dosage Forms
×
Clear all
NCT05216328
2024-11-22
OMAMA
Amsterdam UMC, location VUmc
Phase 4
Recruiting
330 enrolled